Attacking fibrosis on multiple fronts

Fibrosis is characterized by the excessive or abnormal accumulation of extracellular matrix within tissue, leading to organ dysfunction and disease in a range of conditions. There is a high level of unmet need given that the limited treatments available offer only modest benefits, and new drugs are urgently needed.

Jun 12, 2018
Page of


PharmAkea is a biopharmaceutical company based in San Diego, CA. The company is developing high-quality, small molecule drug candidates against protein targets involved in fibroproliferative diseases.

No comments yet.